Genome‐wide association studies of survival in 1520 cancer patients treated with bevacizumab‐containing regimens
Júlia C.F. Quintanilha, Federico Innocenti(AbbVie (United States)), Alexander B. Sibley(Duke University), Kouros Owzar(Duke University), Alan P. Venook(University of California, San Francisco), Osvaldo Espin‐Garcia(Western University), Heinz‐Josef Lenz(USC Norris Comprehensive Cancer Center), D. Y. Lin(University of North Carolina at Chapel Hill), Mark J. Ratain(University of Chicago), Maura N. Dickler(Memorial Sloan Kettering Cancer Center), Hedy L. Kindler(University of Chicago), Jin Wang(Sun Yat-sen University), Geoffrey Liu(Princess Margaret Cancer Centre), Wei Xu(University Health Network), Amy S. Etheridge(University of North Carolina at Chapel Hill), Chen Jiang, Monica M. Bertagnolli(National Institutes of Health)
Cited by 10
Related Papers
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Hepatobiliary Cancers
|Journal of the National Comprehensive Cancer Network|2009|2.3k